Results 21 to 30 of about 1,596,006 (318)
Dyslipidaemia and cardiovascular risk [PDF]
BMJ, 2018 ### What you need to know A 40 year old man visits his general practitioner for annual antipsychotic monitoring. He is taking risperidone and sertraline for a previous diagnosis of psychotic depression. Recent blood tests showed a total cholesterol of 6.0, low density lipoprotein (calculated) (LDLc) 3.8, high density lipoprotein (HDL) 0.8, non-HDL 5.2,
Aidan, Ryan, Simon, Heath, Paul, Cook
openaire +2 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley +1 more source
Vascular function and cardiovascular risk factors in women with severe flushing [PDF]
, 2010 Background: Seventy per cent of postmenopausal women suffer from hot flushes causing significant morbidity in 25%. Oestrogen replacement provides symptom relief, but its use has declined following safety issues and there is, as yet, no good alternative ...
J. Sassarini +9 more
core +1 more source
Cardiovascular risk and obesity [PDF]
Diabetology & Metabolic Syndrome, 2019 This is an overview of the mechanisms of obesity and its relation to cardiovascular risks, describing the available treatment options to manage this condition.The pathogenesis of obesity includes the balance between calories consumed and energy expenditure followed by the maintenance of body weight.
C. Cercato, F. A. Fonseca
openaire +3 more sources
A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho +7 more
wiley +1 more source
Microalbuminuria and cardiovascular risk [PDF]
American Journal of Hypertension, 2004 Microalbuminuria is a marker for generalized vascular dysfunction. Its prevalence in United States and European general population surveys ranges from 6% to 10%. Increased risk for cardiovascular morbidity and mortality begins with albumin excretion rates that are well within normal limits.
Karalliedde, J, Viberti, G
openaire +3 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi +9 more
wiley +1 more source
Cardiovascular risk assessment and management in rheumatoid arthritis : are guidelines being followed? [PDF]
, 2014 Aim: The aim of the audit was to determine whether the cardiovascular risk assessment and management in rheumatoid arthritis patients at Mater Dei Hospital is in concordance with the recommendations by the European League Against Rheumatism (EULAR ...
Borg, Andrew A. +3 more
core
Testosterone and cardiovascular risk [PDF]
The Lancet Diabetes & Endocrinology, 2015 1 Health Canada. Information update: possible cardiovascular problems associated with testosterone products. http://healthycanadians. gc.ca/recall-alert-rappel-avis/hc-sc/2014/ 40587a-eng.php (accessed July 15, 2014). 2 European Medicines Agency. No consitent evidence of an increased risk of heart problems with testosterone medicines.
C Mary, Schooling, Gabriel M, Leung
openaire +2 more sources
Hyperuricemia and Cardiovascular Risk
Cureus, 2021 As the prevalence of hyperuricemia (elevated uric acid levels in the blood) increases, the relationship between serum uric acid levels and cardiovascular risk has garnered increased interest. Several studies have highlighted that elevated uric acid levels are likely tied to increased cardiovascular disease risk.
Shahin, Lauren +3 more
openaire +2 more sources